Personalis, Inc. Common Stock (PSNL)

Price$10.75

Value ScoreF

Growth ScoreF

Momentum ScoreB

Favorite Metrics

Price vs S&P 500 (26W)-7.74%

Price vs S&P 500 (4W)79.78%

VGM Score29.53

Market Capitalization$1.13B

All Metrics

Book Value / Share (Quarterly)$2.43

P/TBV (Annual)0.36x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)2.30%

Cash Flow / Share (Quarterly)$-0.81

Price vs S&P 500 (YTD)26.89%

Gross Margin (TTM)13.72%

Net Profit Margin (TTM)-148.11%

EPS (TTM)$-1.02

10-Day Avg Trading Volume3.41M

EPS Excl Extra (TTM)$-1.02

Revenue Growth (5Y)-2.40%

EPS (Annual)$-0.91

ROI (Annual)-30.50%

Gross Margin (Annual)22.65%

Net Profit Margin (5Y Avg)-122.13%

Cash / Share (Quarterly)$2.23

Revenue Growth QoQ (YoY)-24.91%

ROA (Last FY)-24.32%

Revenue Growth TTM (YoY)-24.71%

EBITD / Share (TTM)$-0.99

ROE (5Y Avg)-45.56%

Operating Margin (TTM)-158.91%

Cash Flow / Share (Annual)$-0.78

P/B Ratio4.42x

P/B Ratio (Quarterly)2.62x

Net Income / Employee (Annual)$-312,600

EV / Revenue (TTM)16.32x

Net Interest Coverage (TTM)-11.43x

ROA (TTM)-32.92%

EPS Incl Extra (Annual)$-0.91

Current Ratio (Annual)6.76x

Quick Ratio (Quarterly)6.31x

3-Month Avg Trading Volume1.96M

52-Week Price Return112.45%

Revenue / Employee (TTM)$248,100

Tangible BV / Share (Quarterly)$3.08

P/S Ratio (Annual)16.16x

Asset Turnover (Annual)0.21x

52-Week High$12.53

Operating Margin (5Y Avg)-122.15%

EPS Excl Extra (Annual)$-0.91

CapEx CAGR (5Y)6.74%

26-Week Price Return0.19%

Quick Ratio (Annual)6.46x

13-Week Price Return25.58%

Total Debt / Equity (Annual)0.02x

Current Ratio (Quarterly)6.61x

Enterprise Value$1.05B

Revenue / Share Growth (5Y)-19.36%

Asset Turnover (TTM)0.22x

Book Value / Share Growth (5Y)-12.55%

Revenue / Employee (Annual)$267,900

Inventory Turnover (Annual)8.92x

Pretax Margin (Annual)-116.66%

Cash / Share (Annual)$2.34

3-Month Return Std Dev94.34%

Gross Margin (5Y Avg)27.34%

Net Income / Employee (TTM)$-367,500

ROE (Last FY)-31.12%

Net Interest Coverage (Annual)-14.75x

EPS Basic Excl Extra (Annual)$-0.91

Receivables Turnover (TTM)5.38x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-1.02

Receivables Turnover (Annual)5.72x

ROI (TTM)-42.98%

P/S Ratio (TTM)17.45x

Pretax Margin (5Y Avg)-122.08%

Revenue / Share (Annual)$0.78

Tangible BV / Share (Annual)$4.67

Price vs S&P 500 (52W)88.08%

Year-to-Date Return35.05%

5-Day Price Return-4.53%

EPS Normalized (Annual)$-0.91

ROA (5Y Avg)-31.54%

Net Profit Margin (Annual)-116.69%

Month-to-Date Return-5.70%

Cash Flow / Share (TTM)$-2.14

EBITD / Share (Annual)$-0.87

Operating Margin (Annual)-126.43%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-44.84%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-1.02

P/TBV (Quarterly)0.51x

P/B Ratio (Annual)2.71x

Inventory Turnover (TTM)9.39x

Pretax Margin (TTM)-148.06%

Book Value / Share (Annual)$2.55

Price vs S&P 500 (13W)17.33%

Beta2.31x

Revenue / Share (TTM)$0.62

ROE (TTM)-43.52%

52-Week Low$3.84

vGradeF

gGradeF

mGradeB

vgmGradeD

Show chart for

Earnings Surprise History

Q1 26-0.29est. -0.28

Analyst Recommendations

Feb 2026

Mar 2026

Apr 2026

May 2026

4.15

Industry Peers — Health Services(28)

Symbol	Value Score	Growth Score	Momentum Score	Price
PSNLPersonalis, Inc. Common Stock	F	F	B	$10.75
NTRANatera, Inc. Common Stock	F	A	C	$215.31
DGXQuest Diagnostics Inc.	C	D	C	$200.29
LHLabcorp Holdings Inc.	C	D	C	$265.15
EXASExact Sciences Corp	F	B	B	$0.00
GHGuardant Health, Inc. Common Stock	F	A	B	$125.61
CAICaris Life Sciences, Inc. Common Stock	F	A	D	$16.49
CELCCelcuity Inc. Common Stock	—	—	C	$88.28
RDNTRadNet, Inc. Common Stock	D	C	C	$54.34
VCYTVeracyte, Inc.	D	A	B	$48.73
GRALGRAIL, Inc. Common Stock	D	A	C	$59.98

About

Personalis Inc provides genomic sequencing and analytics solutions that enable the development of personalized cancer vaccines and cancer immunotherapies. The company's portfolio includes ImmunoID NeXT and related diagnostic tests, serving pharmaceutical companies developing next-generation cancer treatments.